Clinical Trial Update: Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating addition of blinatumomab to standard chemotherapy in newly diagnosed BCR-ABL-negative B-lineage acute lymphoblastic leukemia; results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-09-24